Levodopa/Carbidopa Fairmed

Levodopa/Carbidopa, the active ingredient in Levodopa/Carbidopa Fairmed, is a dopamine precursor/DOPA decarboxylase inhibitor combination presented as an oral dosage form for oral use. It treats Parkinson's disease and Parkinsonian syndrome in adult patients. GNH USA supplies Levodopa/Carbidopa Fairmed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa is used in the management of dopaminergic deficiency disorders, primarily Parkinsonian conditions. - Parkinson's disease: improves motor control by replenishing central dopamine levels. - Parkinsonian syndrome: alleviates rigidity, bradykinesia and tremor associated with secondary Parkinsonism. - Levodopa‑responsive movement disorders: reduces symptoms in conditions that respond to dopamine replacement therapy.

Levodopa/Carbidopa may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Vomiting - Dizziness or light‑headedness - Orthostatic hypotension - Headache - Insomnia

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Hallucinations or other psychiatric disturbances - Severe hypotension or arrhythmias - Neuroleptic malignant‑like syndrome - Anaphylactic or severe allergic reactions

Use of Levodopa/Carbidopa requires careful clinical monitoring. - Blood pressure monitoring: watch for orthostatic drops. - Psychiatric assessment: monitor for hallucinations or mood changes. - Cardiovascular caution: avoid in uncontrolled heart disease. - Renal impairment: dose adjustment may be needed. - Discontinuation: taper gradually to prevent withdrawal symptoms. - Store at room temperature: keep in the original container, protect from moisture and light.

Levodopa/Carbidopa can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors (e.g., phenelzine) - Typical antipsychotics (e.g., haloperidol) - High‑dose pyridoxine (vitamin B6)

Moderate Interactions (Monitor Closely): - Antihypertensive agents (may enhance hypotension) - SSRIs or SNRIs (risk of serotonin syndrome) - Iron or calcium supplements (reduce levodopa absorption)